Tumor Antigen Cross-Presentation and the Dendritic Cell: Where it All Begins?

by Alison M. McDonnell, Bruce W. S. Robinson, Andrew J. Currie
Published 2010-01-01

Auto-antibodies to β-F1-ATPase and vimentin in malignant mesothelioma.

by Jenette Creaney, Ian M Dick, Deborah Yeoman, Sarah Wong, Bruce W S Robinson
Published 2011-01-01

Serial immunomonitoring of cancer patients receiving combined antagonistic anti-CD40 and chemotherapy reveals consistent and cyclical modulation of T cell and dendritic cell parame...

by Alison M. McDonnell, Alistair Cook, Bruce W. S. Robinson, Richard A. Lake, Anna K. Nowak
Published 2017-06-01

Pre-treatment tumor neo-antigen responses in draining lymph nodes are infrequent but predict checkpoint blockade therapy outcome

by Shaokang Ma, Jonathan Chee, Vanessa S. Fear, Catherine A. Forbes, Louis Boon, Ian M. Dick, Bruce W. S. Robinson, Jenette Creaney
Published 2020-01-01

Comparison of the Diagnostic Accuracy of the MSLN Gene Products, Mesothelin and Megakaryocyte Potentiating Factor, as Biomarkers for Mesothelioma in Pleural Effusions and Serum

by Jenette Creaney, Sophie Sneddon, Ian M. Dick, Hanne Dare, Neil Boudville, Arthur William Musk, Steven J. Skates, Bruce W. S. Robinson
Published 2013-01-01

Statins do not alter the incidence of mesothelioma in asbestos exposed mice or humans.

by Cleo Robinson, Helman Alfonso, Samantha Woo, Amy Walsh, Nola Olsen, Arthur W Musk, Bruce W S Robinson, Anna K Nowak, Richard A Lake
Published 2014-01-01

Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma

by Sophie Sneddon, Ann-Marie Patch, Ian M. Dick, Stephen Kazakoff, John V. Pearson, Nicola Waddell, Richard J. N. Allcock, Robert A. Holt, Bruce W. S. Robinson, Jenette Creaney
Published 2017-06-01

Calretinin as a blood-based biomarker for mesothelioma

by Georg Johnen, Katarzyna Gawrych, Irina Raiko, Swaantje Casjens, Beate Pesch, Daniel G. Weber, Dirk Taeger, Martin Lehnert, Jens Kollmeier, Torsten Bauer, Arthur W. Musk, Bruce W. S. Robinson, Thomas Brüning, Jenette Creaney
Published 2017-05-01

Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesothelioma

by Sophie Sneddon, Craig M. Rive, Shaokang Ma, Ian M. Dick, Richard J. N. Allcock, Scott D. Brown, Robert A. Holt, Mark Watson, Shay Leary, Y. C. Gary Lee, Bruce W. S. Robinson, Jenette Creaney
Published 2020-01-01

Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer

by Qingzhu Jia, Luting Chiu, Shuangxiu Wu, Jian Bai, Lina Peng, Linpeng Zheng, Rui Zang, Xueqin Li, Bibo Yuan, Yixing Gao, Dingyong Wu, Xiaohong Li, Lin Wu, Jianguo Sun, Ji He, Bruce W. S. Robinson, Bo Zhu
Published 2020-05-01

Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growth.

by Robbert G van der Most, Andrew J Currie, Amanda L Cleaver, Joanne Salmons, Anna K Nowak, Sathish Mahendran, Irma Larma, Amy Prosser, Bruce W S Robinson, Mark J Smyth, Anthony A Scalzo, Mariapia A Degli-Esposti, Richard A Lake
Published 2009-09-01